Detailed information for compound 1580705

Basic information

Technical information
  • TDR Targets ID: 1580705
  • Name: N-(3,4-dimethoxyphenyl)-4-(4-oxo-2-sulfanylid ene-1H-quinazolin-3-yl)butanamide
  • MW: 399.463 | Formula: C20H21N3O4S
  • H donors: 2 H acceptors: 2 LogP: 2.33 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cc(ccc1OC)NC(=O)CCCn1c(=S)[nH]c2c(c1=O)cccc2
  • InChi: 1S/C20H21N3O4S/c1-26-16-10-9-13(12-17(16)27-2)21-18(24)8-5-11-23-19(25)14-6-3-4-7-15(14)22-20(23)28/h3-4,6-7,9-10,12H,5,8,11H2,1-2H3,(H,21,24)(H,22,28)
  • InChiKey: TVOMJXWOHOTGKQ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-(3,4-dimethoxyphenyl)-4-(4-oxo-2-thioxo-1H-quinazolin-3-yl)butanamide
  • N-(3,4-dimethoxyphenyl)-4-(4-keto-2-thioxo-1H-quinazolin-3-yl)butyramide
  • EU-0094448
  • ZINC02971412
  • Oprea1_113163

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis epidermal growth factor receptor 0.121 0.9254 0.9254
Echinococcus multilocularis insulin growth factor 1 receptor beta 0.0387 0.0134 0.0134
Echinococcus multilocularis carboxylesterase 5A 0.1278 1 1
Echinococcus granulosus melanoma receptor tyrosine protein kinase 0.065 0.3052 0.2958
Schistosoma mansoni tyrosine kinase 0.065 0.3052 0.2958
Schistosoma mansoni tyrosine kinase 0.121 0.9254 0.9243
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.1278 1 1
Echinococcus granulosus epidermal growth factor receptor 0.121 0.9254 0.9243
Echinococcus multilocularis insulin receptor 0.0387 0.0134 0.0134
Echinococcus multilocularis acetylcholinesterase 0.1278 1 1
Echinococcus granulosus carboxylesterase 5A 0.1278 1 1
Loa Loa (eye worm) hypothetical protein 0.1278 1 1
Echinococcus granulosus epidermal growth factor receptor 0.065 0.3052 0.2958
Echinococcus granulosus acetylcholinesterase 0.1278 1 1
Loa Loa (eye worm) TK/EGFR protein kinase 0.121 0.9254 0.9243
Schistosoma mansoni tyrosine kinase 0.0643 0.2977 0.2881
Brugia malayi Furin-like cysteine rich region family protein 0.121 0.9254 0.9243
Schistosoma mansoni tyrosine kinase 0.0643 0.2977 0.2881
Loa Loa (eye worm) hypothetical protein 0.1278 1 1
Schistosoma mansoni tyrosine kinase 0.0643 0.2977 0.2881
Echinococcus multilocularis epidermal growth factor receptor 0.065 0.3052 0.3052
Echinococcus granulosus acetylcholinesterase 0.1278 1 1
Schistosoma mansoni tyrosine kinase 0.065 0.3052 0.2958
Loa Loa (eye worm) acetylcholinesterase 1 0.1278 1 1
Loa Loa (eye worm) carboxylesterase 0.1278 1 1
Echinococcus multilocularis acetylcholinesterase 0.1278 1 1
Brugia malayi Carboxylesterase family protein 0.1278 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) > 50 uM Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human erythrocytes after 48 hrs by FACS analysis ChEMBL. 21958736

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.